GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » Cyclically Adjusted Book per Share

Amcad Biomed (ROCO:4188) Cyclically Adjusted Book per Share : NT$11.59 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Amcad Biomed's adjusted book value per share for the three months ended in Mar. 2025 was NT$8.654. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$11.59 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Amcad Biomed's average Cyclically Adjusted Book Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-30), Amcad Biomed's current stock price is NT$15.10. Amcad Biomed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$11.59. Amcad Biomed's Cyclically Adjusted PB Ratio of today is 1.30.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Amcad Biomed was 2.99. The lowest was 1.15. And the median was 1.85.


Amcad Biomed Cyclically Adjusted Book per Share Historical Data

The historical data trend for Amcad Biomed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed Cyclically Adjusted Book per Share Chart

Amcad Biomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 11.41 11.42 11.55

Amcad Biomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.50 11.49 11.53 11.55 11.59

Competitive Comparison of Amcad Biomed's Cyclically Adjusted Book per Share

For the Medical Devices subindustry, Amcad Biomed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amcad Biomed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Amcad Biomed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Amcad Biomed's Cyclically Adjusted PB Ratio falls into.


;
;

Amcad Biomed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amcad Biomed's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=8.654/134.9266*134.9266
=8.654

Current CPI (Mar. 2025) = 134.9266.

Amcad Biomed Quarterly Data

Book Value per Share CPI Adj_Book
201506 9.391 100.684 12.585
201509 9.063 100.392 12.181
201512 8.715 99.792 11.783
201603 8.348 100.470 11.211
201606 13.018 101.688 17.273
201609 12.801 101.861 16.956
201612 12.577 101.863 16.659
201703 12.305 102.862 16.141
201706 12.041 103.349 15.720
201709 11.809 104.136 15.301
201712 11.500 104.011 14.918
201803 11.546 105.290 14.796
201806 11.323 106.317 14.370
201809 10.977 106.507 13.906
201812 10.605 105.998 13.499
201903 10.459 107.251 13.158
201906 10.361 108.070 12.936
201909 10.094 108.329 12.572
201912 9.842 108.420 12.248
202003 9.323 108.902 11.551
202006 9.362 108.767 11.614
202009 9.252 109.815 11.368
202012 9.150 109.897 11.234
202103 9.028 111.754 10.900
202106 9.000 114.631 10.593
202109 8.959 115.734 10.445
202112 8.879 117.630 10.185
202203 8.758 121.301 9.742
202206 8.613 125.017 9.296
202209 8.259 125.227 8.899
202212 7.804 125.222 8.409
202303 7.645 127.348 8.100
202306 7.407 128.729 7.764
202309 7.200 129.860 7.481
202312 6.991 129.419 7.288
202403 6.697 131.776 6.857
202406 6.566 132.554 6.684
202409 9.084 133.029 9.214
202412 8.979 133.157 9.098
202503 8.654 134.927 8.654

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Amcad Biomed  (ROCO:4188) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Amcad Biomed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.10/11.59
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Amcad Biomed was 2.99. The lowest was 1.15. And the median was 1.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Amcad Biomed Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amcad Biomed Business Description

Traded in Other Exchanges
N/A
Address
No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. Geographically, the company generates revenue from Taiwan, China, Europe, Asia (excluding Taiwan and China), and other countries, out of which the majority of the revenue is generated from Taiwan. The company has two segments: the Medical Diagnostic Software segment, which is responsible for the development and sales of smart medical imaging diagnostic software devices, and the Precision Medical Equipment segment, which is responsible for research, development, manufacturing, and sales of high-end ultrasonic probes. The company generates the majority of its revenue from the Precision Medical Equipment segment.

Amcad Biomed Headlines

No Headlines